Department of Molecular Toxicology, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan
Department of Molecular Toxicology, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan.
Mol Pharmacol. 2019 Jan;95(1):120-126. doi: 10.1124/mol.118.114272. Epub 2018 Nov 5.
The constitutive active/androstane receptor (CAR) controls genes involved in xenochemical metabolism. Although numerous cofactors have been reported to be involved in CAR-mediated transactivation, unknown and poorly defined proteins recruited by CAR have yet to be characterized. In this study, a novel CAR-interacting protein, cell cycle and apoptosis regulator 1 (CCAR1), was identified by coimmunoprecipitation analysis using human hepatocarcinoma HepG2 cells expressing FLAG epitope-tagged CAR. We demonstrated that CCAR1 can act as an enhancer-dependent coactivator of CAR. First, we showed that overexpression of CCAR1 enhanced CAR-induced reporter gene activity with triplicate consensus direct repeat 4 motif (DR4-Luc), xenobiotic-responsive enhancer module (XREM)-enhancer of CYP3A4 (XREM-Luc), and phenobarbital-responsive enhancer module of UDP-glucuronosyltransferases 1A1 (UGT1A1) (gtPBREM)-enhancer of UGT1A1 (gtPBREM-Luc)-driven reporter plasmids but not PBREM-enhancer of CYP2B6 (PBREM-Luc)-driven reporter activity. Furthermore, we showed that knockdown of CCAR1 suppressed CAR-induced mRNA expression but did not affect CAR-induced mRNA expression in HepTR/CAR and HepaRG cells. Moreover, CCAR1 could be recruited to the gtPBREM of the enhancer by CAR but not to the PBREM of the enhancer. Moreover, we showed that CCAR1 can act as a secondary coactivator by cooperating with the p160 family of steroid receptor coactivators (SRCs). These findings demonstrated CCAR1 to be a novel transcriptional cofactor for CAR and provided insight regarding the mechanism of CAR-mediated gene-selective transactivation.
组成型激活/雄烷受体 (CAR) 控制涉及异源化学代谢的基因。尽管已经报道了许多辅助因子参与 CAR 介导的反式激活,但尚未鉴定出由 CAR 募集的未知和定义不明确的蛋白质。在这项研究中,通过使用表达 FLAG 表位标签的人肝癌 HepG2 细胞进行共免疫沉淀分析,鉴定出一种新型 CAR 相互作用蛋白,即细胞周期和凋亡调节剂 1 (CCAR1)。我们证明 CCAR1 可以作为 CAR 的增强子依赖性共激活因子。首先,我们表明,CCAR1 的过表达增强了 CAR 诱导的报告基因活性,具有三倍重复的直接重复 4 基序 (DR4-Luc)、细胞色素 P4503A4 (XREM-Luc) 的外源性反应增强子模块、苯巴比妥反应增强子模块 UDP-葡萄糖醛酸转移酶 1A1 (UGT1A1) (gtPBREM)-UGT1A1 的增强子 (gtPBREM-Luc) 驱动的报告质粒,但不影响 PBREM-细胞色素 P2B6 (PBREM-Luc) 驱动的报告活性。此外,我们表明,CCAR1 的敲低抑制了 CAR 诱导的 mRNA 表达,但不影响 HepTR/CAR 和 HepaRG 细胞中 CAR 诱导的 mRNA 表达。此外,CCAR1 可以通过 CAR 被募集到 增强子的 gtPBREM,但不能被募集到 增强子的 PBREM。此外,我们表明 CCAR1 可以通过与类固醇受体共激活因子 (SRC) 的 p160 家族合作作为二级共激活因子发挥作用。这些发现表明 CCAR1 是 CAR 的一种新型转录共因子,并为 CAR 介导的基因选择性反式激活机制提供了深入了解。